
Jas Velic
patientMale0.0Global Dominance: 0.00%
Jas Velic is a Canadian contractor and father of two who has been battling aggressive multiple myeloma since his diagnosis in January 2023. He has endured a challenging regimen of weekly chemotherapy and is currently seeking access to CAR-T therapy, a cutting-edge treatment that Health Canada approved but has not yet made available for public reimbursement, leaving him and others like him in a prolonged state of uncertainty regarding their treatment options.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jas Velic looks on as lab technician Sasha Gaye Phillips prepares to draw his blood before a weekly chemotherapy session.
Myeloma patients launch campaign advocating for immunotherapy pricing talks to resumeThe Globe and Mail·
Canada· 2025-11-03
Jas Velic is a patient suffering from aggressive blood cancer who is seeking access to CAR-T therapy.
Canadians can wait years to get drugs regulators have already deemed safe. Why?The Globe and Mail·
Canada· 2025-10-31














